Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Eluting Stent in Choanal Atresia
NCT03605537Phase 4Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of mometasone in choanal atresia (CA) (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Assessment of Posterior Nasal Cavity at 12 months. Planned start Jul 2018; status: withdrawn.
02
Drugs
mometasone
03
Conditions
choanal atresia (CA)
Beyond the preview
Go deeper on NCT03605537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03605537.